ID
38913
Description
Study ID: 110951 Clinical Study ID: 110951 Study Title: A two-part, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of intravenously infused GSK1995057 in healthy subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01476046 See https://clinicaltrials.gov/ct2/show/NCT01476046 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: N/A, Placebo Trade Name: N/A Study Indication: Respiratory Disorders This phase I trial primarily studies the safety and tolerability of ascending single intravenous doses of the selective TNFR1 antagonist GSK1995057 in healthy volunteers, and secondly explores the drug's pharmacodynamics, pharmacokinetics, concentration in lung epithelial lining fluid as well as its effect on immune system markers. The drug is hypothesized to be useful for Acute Lung Injury. The single-centre study consists of two parts A and B with seven cohorts/ten subcohorts in total. Part A includes ascending doses of the investigational product given to subjects negative or positive for pre-existing human anti-heavy chain variable domain (HAVH) antibodies (Cohorts 1 to 3 with Subcohorts 1a, 2a and 3a negative for HAVH and 1b, 2b, 3b positive for HAVH). Part B includes only subjects negative for HAVH, with ascending doses given to Cohorts 4 to 6. Cohort 7 receives the same dose as Cohort 6, but whereas the other Cohorts are single-blinded, Cohort 7 is open-label and additionally receives a bronchoalveolar lavage (BAL). The study consists of a Screening Visit (up to 56 days before Day 1, the day of the drug administration), Visits on Day -1, 1, 2, 3, 5, 7, 14, 28 and Follow-Up Visits on Day 57 and 85. This form contains information on protocol deviations, and is filled in by the Sponsor's (GSK) monitoring staff only.
Lien
https://clinicaltrials.gov/ct2/show/NCT01476046
Mots-clés
Versions (2)
- 25/10/2019 25/10/2019 -
- 12/11/2019 12/11/2019 - Sarah Riepenhausen
Détendeur de droits
GlaxoSmithKline
Téléchargé le
12 novembre 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Phase I Trial of Intravenous TNFR1 Antagonist GSK1995057 in Healthy Subjects - NCT01476046
Protocol Deviation
- StudyEvent: ODM
Description
Protocol Deviations
Alias
- UMLS CUI-1
- C1705236
Description
Protocol Deviation Number
Type de données
integer
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C0600091
Description
[hidden]
Type de données
integer
Alias
- UMLS CUI [1]
- C2826182
Description
[hidden] Specify Other protocol deviation below; select sub-category for Visit window, Administer/Dispense Study Medication, Study Treatment Supply Procedures, Biological Specimen Sample Procedures, Equipment Procedures, Randomization Procedures
Type de données
text
Alias
- UMLS CUI [1]
- C1705236
Description
Specify other protocol deviation
Type de données
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C1705236
- UMLS CUI [1,3]
- C1521902
Description
Protocol deviation: Visit
Type de données
text
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C0545082
Description
Specify other Protocol Deviation: Visit
Type de données
text
Alias
- UMLS CUI [1,1]
- C1521902
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C1705236
- UMLS CUI [1,4]
- C0545082
Description
Protocol Deviation: Administration/Dispensing Study Medication
Type de données
text
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C0304229
- UMLS CUI [2,1]
- C1705236
- UMLS CUI [2,2]
- C1533734
- UMLS CUI [2,3]
- C0304229
Description
Specify other Protocol Deviation: Administration/Dispensing Study Medication
Type de données
text
Alias
- UMLS CUI [1,1]
- C1521902
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C1705236
- UMLS CUI [1,4]
- C1880359
- UMLS CUI [1,5]
- C0304229
- UMLS CUI [2,1]
- C1521902
- UMLS CUI [2,2]
- C0205394
- UMLS CUI [2,3]
- C1705236
- UMLS CUI [2,4]
- C1533734
- UMLS CUI [2,5]
- C0304229
Description
Protocol Deviation: Study Treatment Supply
Type de données
text
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C0243163
- UMLS CUI [1,3]
- C0304229
Description
Specify other Protocol Deviation: Study Treatment Supply
Type de données
text
Alias
- UMLS CUI [1,1]
- C1521902
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C1705236
- UMLS CUI [1,4]
- C0243163
- UMLS CUI [1,5]
- C0304229
Description
Protocol Deviation: Biological Specimens
Type de données
text
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C2347026
Description
Specify other Protocol Deviation: Biological Specimens
Type de données
text
Alias
- UMLS CUI [1,1]
- C1521902
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C1705236
- UMLS CUI [1,4]
- C2347026
Description
Protocol Deviation: Equipment
Type de données
text
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C0014672
Description
Specify other Protocol Deviation: Equipment
Type de données
text
Alias
- UMLS CUI [1,1]
- C1521902
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C1705236
- UMLS CUI [1,4]
- C0014672
Description
Protocol Deviation: Randomization
Type de données
text
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C0034656
Description
Specify other Protocol Deviation: Randomization
Type de données
text
Alias
- UMLS CUI [1,1]
- C1521902
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C1705236
- UMLS CUI [1,4]
- C0034656
Description
[hidden]
Type de données
text
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C0678257
Description
[hidden]
Type de données
partialDate
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1880355
- UMLS CUI [1,3]
- C1705236
Description
[hidden]
Type de données
text
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C1547656
Description
[hidden]
Type de données
text
Alias
- UMLS CUI [1,1]
- C1705236
- UMLS CUI [1,2]
- C0031831
- UMLS CUI [1,3]
- C2347796
- UMLS CUI [1,4]
- C1283169
Similar models
Protocol Deviation
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C1705236 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
C0545082 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
C1705236 (UMLS CUI [1,3])
C0545082 (UMLS CUI [1,4])
C1880359 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C1705236 (UMLS CUI [2,1])
C1533734 (UMLS CUI [2,2])
C0304229 (UMLS CUI [2,3])
C0205394 (UMLS CUI [1,2])
C1705236 (UMLS CUI [1,3])
C1880359 (UMLS CUI [1,4])
C0304229 (UMLS CUI [1,5])
C1521902 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C1705236 (UMLS CUI [2,3])
C1533734 (UMLS CUI [2,4])
C0304229 (UMLS CUI [2,5])
C0243163 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])
C1705236 (UMLS CUI [1,3])
C0243163 (UMLS CUI [1,4])
C0304229 (UMLS CUI [1,5])
C2347026 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
C1705236 (UMLS CUI [1,3])
C2347026 (UMLS CUI [1,4])
C0014672 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
C1705236 (UMLS CUI [1,3])
C0014672 (UMLS CUI [1,4])
C0034656 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
C1705236 (UMLS CUI [1,3])
C0034656 (UMLS CUI [1,4])
C0678257 (UMLS CUI [1,2])
C1880355 (UMLS CUI [1,2])
C1705236 (UMLS CUI [1,3])
C1547656 (UMLS CUI [1,2])
C0031831 (UMLS CUI [1,2])
C2347796 (UMLS CUI [1,3])
C1283169 (UMLS CUI [1,4])